Study Type : Interventional (Clinical Trial)Estimated Enrollment : 200 participantsAllocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: TreatmentOfficial Title: A Phase 2b, Randomized, Double Blind, Two Arm Study to Investigate the Effects of BNC210 Tablet Formulation Compared to Placebo in Adults With Post-Traumatic Stress Disorder (PTSD)Actual Study Start Date : July 27, 2021Estimated Primary Completion Date : July 2023Estimated Study Completion Date : August 2023
ATTUNE trial
BNO Price at posting:
1.3¢ Sentiment: Hold Disclosure: Held
